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Abstract
Introduction:  Recent  studies  certify  the existence of  link  between Alzheimer's  disease and
cardiovascular pathology, however the mechanisms of this phenomenon is unclear. Here we
studied  the  influence  of  Alzheimer's  β-amyloid  peptide  (βAP)  on  the  contractility  of  rat
myocardium and aorta. Material and methods: Contractility of myocardium ventricle strips and
transverse fragments of abdominal aorta was measured at Power Lab setup using conventional
myographic technique. Contractile responses of  aorta strips were evoked by application of
receptor agonists, contractile responses of myocardium - by electrical stimulation. Contractile
responses of aorta strips after application of carbachol (10-6-10-4 M), histamine (10 -6-10-4 M),
norepinephrine (10-5-10 -3 M) and ATP (10-6-10-4 M) were measured. Results and discussion:
We found the impairment of carbachol- and histamine-induced contractility of aorta, appearing
as perverse contractile reactions (relaxation instead of contraction) under the action of βAP (10-
6 M). Next, we found βAP-induced impairments of ventricle myocardium contractility, appearing
as decrease of relaxation phase duration and increase of relaxation speed (positive lusitropic
effect). Also, own positive lusitropic effect of norepinephrine was absent in presence of βAP (10 -
6M). Thus, βAP(25-35) significantly impairs the contractility of rat myocardium and aorta, as well
as  processes  of  its  regulation.  Obtained  data  significantly  broad  our  understanding  of
mechanisms  of  Alzheimer's  disease  pathogenesis  and  pathophysiology  of  cardiovascular
system.
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